the ability of sera from cardiomyopathic patients to inhibit the binding of [ 3h ] dihydroalprenolol to rat cardiac membranes was significantly higher than that of the other two patient groups ( 40 +/- 5 % at 50-fold serum dilution compared to 14 +/- 3 % for the ischemic/valvular heart disease group , and 14 +/- 4 % for the normal control group , p less than 0.001 ) .
C0878544
cardiomyopathic
C0018787
cardiac